BIODENTINE AS A BIOCOMPATIBLE RETROGRADE FILLING MATERIAL WITH PLATELET-RICH FIBRIN (PRF) AS AN AUTOLOGOUS BIOMATERIAL IN THE MANAGEMENT OF PERIAPICAL LESION
Abstract
The successful treatment of periapical inflammatory lesion depends on the reduction and elimination of the offending organism. Periapical surgery, one of the treatment alternatives, includes the curettage of all periapical soft tissues and sometimes application of different biomaterials to enhance the new bone formation in the defect site like using platelet-rich fibrin (PRF) which acts as a source of growth factors at the healing site. PRF features all the necessary parameters permitting optimal healing. A cystic lesion, which is unable to heal non-surgically, heals well with surgical intervention and use of mineral trioxide aggregate (MTA) as retrograde filling has been reported in literature. Another material with largely improved handling properties; Biodentine™ (Septodont, St. MaurdesFossés, France) was introduced in 2011. It is a calcium silicate based material and manufacturers claim that it can be used for crown and root dentin repair treatment, repair of perforations or resorptions, apexification, and root end fillings. This article presents a case of surgical management of a large cystic lesion using Biodentine™ as retrograde filling material.
Keywords
Full Text:
PDFReferences
Abramovitz I, Better H, Shacham A, Shalomi B, Metzger Z. Case Selection for apical surgery: A retrospective evaluation of associated factors and rational. J Endod 2002;28:527‑30.
Ahmed HM, Al Rayes MI, Saini D. Management and prognosis of teeth with traumatic induced crown fractures and large periapical cyst like lesions following apical surgery with and without retrograde filling. J Conserv Dent 2012;15:77-9.
Choukroun J, Adda F, Schoeffl er C, Vervelle A. Une opportunite´ enparo-implantologie: le PRF. Implantodontie 2000;42:55-62.
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): A second generation platelet concentrate-part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E56-60.
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): A second generation platelet concentrate-part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E299-303.
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): A second generation platelet concentrate-part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E56-60.
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): A second generation platelet concentrate-part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod 2006;101:E299-303.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): A second generation platelet concentrate-part I: Technological concept and evolution. Oral Surg Oral Med Oral Path Oral Radiol Endod 2006;101:E37-44.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate-part II: Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E45-50.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate-part III: leukocyte activation: A new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E51-5.
Refbacks
- There are currently no refbacks.